Literature DB >> 9519336

The Münster Heart Study (PROCAM). Results of follow-up at 8 years.

G Assmann1, P Cullen, H Schulte.   

Abstract

The Münster Heart Study (PROCAM) was initiated in 1979 in order to examine cardiovascular risk factors, cardiovascular events including myocardial infarction and stroke, and mortality in people at work. Examination at entry comprised a standardized case history, measurement of blood pressure and anthropometric data, a resting electrocardiogram, and measurement of more than 20 laboratory parameters in a fasting blood sample. The prevalence data in this report are based upon a single examination of 17,437 men aged 40.4 +/- 11.3 years (mean +/- SD) and 8065 women aged 35.7 +/- 12.1 years, which took place between 1979 and 1991. Severe hypercholesterolaemia (> 300 mg.dl-1) was seen in 5% of men and 8% of women aged 45 to 64 years. In men, the prevalence of hypertriglyceridaemia (> 200 mg.dl-1) rose from 5% at age 20 to 20% at age 45 and remained constant thereafter; in women the prevalence of hypertriglyceridaemia increased linearly from 2% at age 20 to 7% at age 60. The LDL/HDL ratio was higher in men than in women at all age groups; in the age group 45 to 64 years, LDL/HDL ratios > 5 were approximately twice as common in men. Lipoprotein(a) levels were distributed in a highly skewed fashion. In men, a slight rise in the geometric mean lipoprotein(a) concentration occurred with age, whereas in women a dramatic increase was seen after age 40. Using multivariate analysis by the multiple logistic function method, total cholesterol, HDL cholesterol, LDL cholesterol and log-transformed triglycerides showed a significant (P < 0.001) age-adjusted correlation with the presence of major coronary events. A risk algorithm has been developed for men aged 40 to 65 years which takes into account the independent risk factors of HDL cholesterol, LDL cholesterol, triglycerides, fibrinogen, age, systolic blood pressure, cigarette smoking, presence of diabetes mellitus and family history of myocardial infarction and angina pectoris. This algorithm can be used in clinical practice to calculate the 8-year risk of an individual suffering a myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9519336

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  49 in total

1.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

2.  Patterns and determinants of dyslipidaemia in 'Young' versus 'Not so Young' patients of coronary artery disease: a multicentric, randomised observational study in northern India.

Authors:  Nakul Sinha; Sudeep Kumar; Himanshu Rai; Neha Singh; Aditya Kapoor; Satyendra Tewari; R K Saran; V S Narain; R P S Bharadwaj; R K Bansal; P C Saxena; P R Sinha; P R Gupta; Mukul Mishra; Praveen Jain; C M Pandey; Uttam Singh; S S Agarwal
Journal:  Indian Heart J       Date:  2012 May-Jun

Review 3.  Best practice in primary care pathology: review 3.

Authors:  W S A Smellie; J Forth; D Bareford; P Twomey; M J Galloway; E C M Logan; S R S Smart; T M Reynolds; C Waine
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

4.  Study of molecular mechanism of Prostaglandin E1 in inhibiting coronary heart disease.

Authors:  H J Liu; J W Ma; Z Y Qiao; B Xu
Journal:  Mol Biol Rep       Date:  2013-10-22       Impact factor: 2.316

5.  Should both HDL-C and LDL-C be targets for lipid therapy? A review of current evidence.

Authors:  B Greg Brown; Xue-Qiao Zhao; Marian C Cheung
Journal:  J Clin Lipidol       Date:  2007-02-15       Impact factor: 4.766

6.  Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.

Authors:  Hagai Tavori; Yan Ru Su; Patricia G Yancey; Ilaria Giunzioni; Ashley J Wilhelm; John L Blakemore; Manal Zabalawi; MacRae F Linton; Mary G Sorci-Thomas; Sergio Fazio
Journal:  J Lipid Res       Date:  2015-01-15       Impact factor: 5.922

Review 7.  Fibrate therapy in the management of diabetic dyslipidemia: there is no ACCORD to be found.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2010-09       Impact factor: 5.113

8.  Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study [corrected].

Authors:  Alon Schaffer; Monica Verdoia; Ettore Cassetti; Lucia Barbieri; Pasquale Perrone-Filardi; Paolo Marino; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

Review 9.  Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy.

Authors:  Yun Lin; Shaymaa S Mousa; Nabil Elshourbagy; Shaker A Mousa
Journal:  Vasc Health Risk Manag       Date:  2010-03-03

Review 10.  Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention.

Authors:  Jesús Millán; Xavier Pintó; Anna Muñoz; Manuel Zúñiga; Joan Rubiés-Prat; Luis Felipe Pallardo; Luis Masana; Alipio Mangas; Antonio Hernández-Mijares; Pedro González-Santos; Juan F Ascaso; Juan Pedro-Botet
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.